| Fund ID | 805-5029454480 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Solas Bioventures Fund II, LP | Venture Capital | $34.3M |
| Solas Francis Sidecar | Venture Capital | $24.5M |
| Solas Tvardi Sidecar | Venture Capital | $13.5M |
Solas Bioventures Emerging Healthcare Fund, LP reports $51.9 million in gross assets, among the top 54% of private funds by size.
The stated minimum investment is $1 million.
Solas Bioventures Emerging Healthcare Fund, LP is managed by Solas Bioventures Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.